Hims Hers Health Inc (HIMS) Stock Forecast & Price Target
Hims Hers Health Inc · NYSE
$29.37-0.87 (-2.88%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 14 firms covering Hims Hers Health Inc, 4 rate it Buy or better, 10 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets range widely, $21.00 to $60.00 (about 2.9x), a sign of real disagreement on valuation. The average target of $32.00 sits 9% above the current $29.37. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.06 next quarter toward $0.67 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS14 ratings
Moderate Buy
Strong Buy00%
Buy429%
Hold1071%
Sell00%
Strong Sell00%
Based on 14 analysts giving stock ratings to Hims Hers Health Inc.
As of Jul, 4 of 14 firms rate HIMS a Buy (10 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
HIMS EPS & revenue forecast
EPS · NEXT QUARTER
$0.06
Range $0.06 – $0.06 · 1 analysts · +0% YoY
Next period, 1 analysts expect Hims Hers Health Inc to earn $0.06 a share (range $0.06 – $0.06), versus $0.06 a year earlier. Full-year consensus is $-0.08, growing to $0.67 the year after.
REVENUE · NEXT QUARTER
$887.0M
Range $887.0M – $887.0M · 1 analysts · +48% YoY
Revenue is expected to reach $887.0M (range $887.0M – $887.0M), +48.1% year-over-year. Full-year consensus is $3.0B, rising to $4.5B next year.
Top analysts covering Hims Hers Health Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on HIMS.
#1
Justin Patterson
Keybanc · Rank #329
Hold
No targeton HIMS
Overall win rate
26%
+ Follow
#2
Ryan MacDonald
Needham · Rank #386
Buy
$35.00+19.2% to target
Overall win rate
17%
+ Follow
#3
Allen Lutz
B of A Securities
Hold
$37.00+26.0% to target
Coverage
—
+ Follow
#4
GS
Glen Santangelo
Barclays
Buy
$39.00+32.8% to target
Coverage
—
+ Follow
#5
Daniel Grosslight
Citigroup
Hold
$28.00-4.7% to target
Coverage
—
+ Follow
HIMS stock forecast FAQ
What is HIMS's average 12-month price target?+
The 12 analysts with a live target average $32.00 for Hims Hers Health Inc over the next 12 months, ranging from a $60.00 high to a $21.00 low.
Is HIMS stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 14 analyst ratings, 4 are Buy or Strong Buy, 10 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for HIMS?+
The Street-high target is $60.00, and the Street-low is $21.00 (Morgan Stanley). The average of all 12 active targets is $32.00.
How many Wall Street analysts cover HIMS?+
14 analysts have an active rating on Hims Hers Health Inc, and 12 firms carry a live 12-month price target.
Who is the most accurate analyst covering HIMS?+
Among analysts who currently cover HIMS, Justin Patterson of Keybanc has the strongest overall Quantellect track record (Rank #329). Their current call is Hold.
What is Hims Hers Health Inc's projected EPS for next quarter?+
The consensus estimate is $0.06 per share (range $0.06 – $0.06) across 1 analysts. Full-year EPS is projected at $-0.08, rising to $0.67 the following year.
How much revenue is Hims Hers Health Inc expected to report next quarter?+
Consensus revenue is $887.0M (range $887.0M – $887.0M). Full-year revenue is projected at $3.0B, growing to $4.5B next year.
Have analysts been upgrading or downgrading HIMS lately?+
As of Jul, 4 of 14 firms rate HIMS a Buy (10 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their HIMS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
